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MOLDING METHOD AND BIOCOMPOSITE MATERIALS 
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Peter2 and Zhou, Jack.1 
1Dept. of Mechanical Engineering and Mechanics, 2School of Biomedical Engineering, Science and 
Health Systems, Drexel University, Philadelphia, PA 19104, USA 
 
Abstract: Drop on demand printing (DDP) is a solid freeform fabrication (SFF) technique capable of generating 
physical features required for scaffolds to be used in hard tissue repair. Here we report results toward the development 
of a reproducible manufacturing process for tissue engineering scaffolds based on injectable porogens fabricated by 
DDP. Thermoplastic porogens were designed using Pro/Engineer and fabricated with a commercially available DDP 
machine. Scaffolds composed of either pure polycaprolactone (PCL) or homogeneous composites of PCL and calcium 
phosphate (CaP, 10% or 20% w/w) were subsequently fabricated by injection molding of molten polymer-ceramic 
composites. The precisely formed scaffolds were separated from the porogens in an agitated ethanol bath. Attainable 
scaffold pore sizes using the porogen-based method were found to be 200 µm for pure PCL. We characterized the 
compressive strength of 90:10 and 80:20 PCL-CaP composite materials (19.5+/-1.4 MPa and 24.8+/-1.3MPa 
respectively) according to ASTM standards, as wells as pure PCL scaffolds (13+/-1.2 MPa) fabricated using our process. 
Initial cell-biomaterial interaction studies demonstrated that our PCL and 80:20 PCL-CaP composite scaffolds 
supported attachment and proliferation of human embryonic palatal mesenchymal (HEPM) cells, as evidenced by 
fluorescent nuclear staining and the Alamar Blue™ assay. Scanning electron microscopy (SEM) revealed that HEPM 
cells spread and demonstrated histiotypic mesenchymal morphology.  
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1. Introduction 
Tissue engineering is an interdisciplinary field that 
draws from materials science, cell biology, and 
biotechnology to synthesize effective strategies for repair 
or replacement of damaged or diseased tissues[1]. 
Typically, in vitro bone tissue engineering uses 
engineered 3-D scaffolds[2], made of synthetic 
biodegradable polymers[3] or bioceramics[4], as substrates 
for 3-D culture of osteoblasts or other applicable cell 
types. 
The recent application of solid freeform fabrication 
(SFF) to manufacturing scaffolds for tissue engineering[5-8] 
is limited by the fact that SFF machines must be adapted 
to the fluid mechanical properties of each biomaterial 
under consideration. For drop-on-demand- printing(DDP) 
and fused deposition modeling, the machine parameters 
must match the physical properties of the build material, 
i.e. viscosity and surface tension. These properties vary 
greatly amongst different biomaterials, making the use of 
a single machine for direct fabrication of scaffolds from 
multiple biomaterials difficult. Therefore it is desirable to 
develop SFF fabrication processes in which a single, 
universal porogen material is used to build porogens that 
may then be injected with a wide range of biomaterials. 
The innate rigidity of the synthetic biodegradable 
polymer polycaprolactone (PCL) makes this material well 
suited for the fabrication of tissue engineering scaffolds, 
mainly for orthopedic applications[9,10]. Calcium 
phosphate(CaP), a major constituent of native 
extracellular matrix(ECM) in bone[11], is frequently used 
as a scaffold material for bone tissue engineering[12-14]. In 
the past, we designed and implemented a thermoplastic 
porogen-based process for the fabrication of 
cytocompatible injection molded calcium phosphate 
cement (CPC) scaffolds[15]. In extending these studies, we 
now used two well-defined biomaterials, PCL and CaP, to 
generate cytocompatible scaffolds with precise 
architectural features and appropriate mechanical 
properties for hard tissue repair by injection molding of 
thermoplastic porogens fabricated by DDP. 
 
2. Materials and Methods 
2.1. Drop-on-Demand Printing Machine 
   All thermoplastic porogens were fabricated using a 
commercial DDP machine (Solidscape™ ModelMaker II,) 
based on thermoplastic ink jetting technology (Figure 1). 
Porogens were built based on a simplified CAD model 
generated using Pro/EngineerTM (Figure 2). 
2.2 Structured Porogen Design 
The Pro/EngineerTM-designed injectable porogen 
model with 100% interconnectivity is shown in Figure 3. 
Each void of the square scaffold is in the shape of a cube 
and is separated from adjacent voids by struts on four of 
its sides. Scaffolds were designed with pore sizes of 
600µm, 400µm, 300µm and 200µm. In previous studies, 
generation of biocompatible scaffolds using injectable 
porogens has been accomplished by polymer solution 
casting[6]. However, most of the solvents which are 
commonly used to solubilize synthetic biopolymers, such 
as dimethyl formamide, chloroform, and dioxane, will 
also dissolve the proprietary thermoplastic material used 
with the Solidscape™ machine, making solution casting 
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difficult to implement in our process. Therefore, in order 
to use the parts fabricated by the machine without any 
secondary processing[6], we chose to inject molten 
biopolymers into the porogen. 
  
 
 
Figure 1: Diagram of Solidscape Modelmaker II RP 
system A: Inkjet printhead; B: Process diagram.  
                                                          
A  
B  C  
 
Figure 2: Computer generated models of the scaffold 
porogen. A: Injectable porogen; B: Overhead view shows 
the single injection gate; C: Resultant scaffold consisting 
of pores (200, 300, 400, or 600 m　 3). 
 
In order to empirically determine the minimum 
porogen basin wall thickness and maximum biomaterial 
injection temperature for which thermoplastic porogens 
would consistently maintain structural integrity, simple 
destructive testing was conducted. Based on these 
preliminary experiments a 3.18mm wall thickness and a 
biomaterial injection temperature of 75°C were selected. 
In order to minimize air entrapment and weld line 
formation, the porogen was designed such that molten 
biomaterial would flow into the cavities of the porogen 
through a single injection gate (Figure 2B). The 
dimensions of the port were equal to the pore size of the 
particular scaffold being injected. Therefore a transition 
region was needed to go from a relatively large basin 
where molten material could be deposited down to the 
gate dimension corresponding to the desired pore size of 
the scaffold (Figure 2B). The interior diameter of the 
basin was designed such that the plunger of a standard 
plastic 1 ml syringe could be used to force the molten 
biomaterial into the cavities of the porogen (Figure 2A).  
2.3 Fabrication of Scaffolds:  
Following fabrication of structured thermoplastic 
porogens, scaffolds were generated by injection molding 
as described below. The overall process is illustrated in 
Figure 2A. 
PCL Scaffolds: PCL pellets (average molecular weight = 
65,000, Sigma) were melted in an oven (VWR 1410) at 
75ºC. Concomitantly, the porogens were also preheated to 
75C. Molten PCL was drawn into a 1 ml syringe. The flat 
tip of the syringe was placed into the basin, thus allowing 
the plunger to advance from the syringe body into the 
basin of the porogen (Figure 2A). The syringe was 
emptied quickly and the filled porogen was allowed to 
cool. After solidifying, excess PCL was trimmed. In order 
to separate the porogen from the scaffold structure after 
biomaterial solidification, the filled porogens were 
immersed into 99% ethanol (Fisher) in a 10ml test tube. 
The tube was shaken vigorously and the solvent replaced 
every 15-20 seconds, until all porogen material was 
dissolved, as evaluated by the colorless appearance of the 
solvent. After porogen removal, the scaffolds were then 
allowed to air-dry at room temperature. A cutout view of 
the scaffold structure corresponding to the porogen design 
is shown in Figure 2C. 
PCL-CaP Composite Scaffolds: PCL-CaP composite 
scaffolds were fabricated in the same fashion as the PCL 
scaffolds, with the additional step of preparing the 
PCL-CaP composite. For that, dry PCL pellets and CaP 
powders were weighed and mixed at the desired ratios in 
an aluminum specimen dish. After melting at 75ºC, the 
mixture was homogenized using an ultrasonic probe, and 
reheated as necessary; total mixing time was about 30 
minutes. Scaffolds were made with ratios (w/w) of 90% 
PCL to 10% CaP and 80% PLC to 20% CaP. 
2.4 Scanning Electron Microscopy (SEM) of Calibration 
Blocks and Scaffolds 
Porogens and scaffold structures were prepared for 
characterization by SEM according to standard 
protocol[16]. Briefly, non-biological samples (porogens 
and empty scaffolds) were air-dried and sputter coated 
with Au/Pd for a period of 60-120 seconds depending on 
sample architecture. Biological samples (cell-seeded 
scaffolds) were fixed in 2.5 % aqueous gluteraldehyde for 
1 hour at room temperature then overnight at 4ºC, 
dehydrated through graded alcohols, dried with a critical 
point dryer (SPI supplies). All samples were examined 
with a SEM (XL-30 Environmental SEM-FEG). 
2.5 Mechanical Testing 
Compression tests of solid rods made of PCL and 
PCL-CaP were performed on an Instron 5543 uniaxial 
testing system using 1KN load cell. Five specimens of 
each material were tested according to the guidelines 
specified in ASTM D695-02a[17]. In addition, 
compression testing was done on 600µm pore pure PCL 
scaffolds (n=6) at a compression rate of 1mm/min using 
the same system described above with a 100N load cell. 
Effective stress was computed based on the scaffold 
cross-sectional area. The ultimate compressive strength 
(UCS) as well as the compression modulus (CM) was 
calculated from the effective stress-strain diagrams, as 
previously described [17]. 
2.6 Cell Culture 
The cytocompatibility of the scaffolds was assessed 
using human embryonic palatal mesenchymal cells 
(HEPM, ATCC, CRL-1486). These cells are routinely 
maintained in Eagles’ minimum essential medium (MEM) 
with Earles’ salts supplemented with 10% fetal bovine 
serum (Hyclone), 2.0mM L-glutamine, 1.0mM sodium 
pyruvate, 0.1 mM non-essential amino acids, and 1.5g/L 
sodium bicarbonate at 37°C in a 5% CO2 incubator[16]. 
For cell culture studies, the scaffolds were sterilized with 
A B
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70% ethanol for 1 hour, and washed 3 times with sterile 
phosphate buffered saline (PBS). The scaffolds were then 
incubated with a mixture of 30µg/ml collagen type I (BD 
Biosciences) and Matrigel™ (BD Biosciences, diluted 
1:30) in MEM for 1 hour at 37°C to facilitate ECM 
protein adsorption and enhanced cellular attachment. 
Scaffolds were then seeded with a suspension of 1 million 
cells/ml overnight on an orbital shaker (Belly Dancer, 
Stovall). Following seeding, scaffolds were transferred to 
24-well plates, allowed to equilibrate for 2 hours in the 
described cell culture medium and the initial level of cell 
seeding was assessed by the Alamar Blue (Biosource) 
assay[16]. In order to assess cell proliferation on the 
various scaffolds the Alamar Blue assay was performed 
again on the same samples at day 4 post-seeding. 
Subsequently, the samples were fixed in 10% buffered 
formalin (Fisher) for 1 hour at room temperature and 
stored in PBS at 4°C until cytological staining. For 
staining, the samples were washed once more with PBS 
and incubated with PBS containing 2µg/mL Hoechst 
33258 (Bisbenzimide, Sigma), a nuclear stain. 
2.7 Statistical analysis 
All data are presented as means ± standard deviation 
(SD). For each experiment, the number of samples for 
each scaffold was 5. Statistical significance of Alamar 
Blue™ measurements was assessed by one way ANOVA 
with Tukey-Cramer post-tests for multiple comparisons, 
defining P < 0.05 as significant. Due to unequal variance, 
comparisons for the compressive testing were performed 
with one tailed t-test followed by the Welch correction for 
significantly different standard deviations. 
                          
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: SEM of scaffolds, magnification and scale bar 
indicated in images. A: Thermoplastic porogen used for 
fabrication of 400µm scaffolds; B: PCL scaffold, 300µm 
pores. C: PCL-CaP composite scaffold, 600µm pores. D: 
PCL scaffold, single pore ~ 200µm.  
 
3. Results and Discussion 
3.1 Scaffold Fabrication 
Using the thermoplastic porogens, we successfully 
generated PCL and PCL-CaP composite scaffolds by 
injection molding of molten polymer. Using these 
porogens, we then fabricated PCL and PCL-CaP 
composite scaffolds with nominal void sizes of 300, 400, 
and 600µm. The measured pore sizes of our scaffolds, as 
evaluated from SEM micrographs, conformed well to the 
predicted sizes, based on the designs of the porogens. The 
measured pore sizes of pure PCL scaffolds fabricated 
using thermoplastic porogens with void spaces of 400 and 
600µm were 396 ± 40µm and 607±12µm (n=12). In 
addition, PCL scaffolds with 200µm pore diameters were 
fabricated. 
We note that other SFF systems have been able to 
generate structures with features of 200µm or less using 
direct building methods with PCL[18-20]. Notably, using a 
solution casting approach, Vozzi et al.[20] developed a 
microsyringe deposition system capable of generating 
deposition line widths as low as 20µm using a 2.5% poly- 
L-lactic acid (PLLA)/20% PCL solution. However, the 
manufacturing process reported by these authors was 
limited to by the fact that it did not allow for the effective 
fabrication of macroscopic 3-D scaffolds. 
The pore sizes in our scaffolds are comparable with 
some of the highest resolution SFF systems capable of 
fabricating 3-D macroscopic scaffolds reported in the 
literature. For example, Geng et al.[5] reported pore sizes 
of 200-500µm using a direct printing system with the 
polysaccharide chitosan. Darling and Sun[18] used 
precision extrusion deposition of computer-aided design 
(CAD) models to fabricate PCL scaffolds with pore sizes 
and strut widths of 200-300µm. Similarly, Zein et al.[19] 
used a fused deposition modeling of CAD models to 
fabricate PCL scaffolds with pore sizes of 160-700µm 
and deposited fibers of 260-370µm. All of these direct 
build SFF methods are limited by the fact that the 
manufacturing process must be re-configured for each 
material used. By contrast, in our approach the ubiquitous 
porogen is more versatile. The machine must be 
configured only once for the ubiquitous porogen which 
may then be filled with any biomaterial having a melting 
temperature below 75°C. 
Taboas et al.[6] used an indirect thermoplastic porogen 
approach comparable to our process. However their 
process is complicated by the fact that an additional step 
of casting ceramic into the thermoplastic is required. Thus, 
upon dissolution of the thermoplastic, Taboas et al. 
injection-molded poly-lactic acid (PLA) into the ceramic 
to generate scaffolds with macropore sizes of 500µm and 
an internal microporous structure on the order of 
50-100µm produced by salt leaching. Our process, which 
intrinsically is simpler than that of Taboas et al, is easily 
amenable to the introduction of salt leaching approaches; 
it would require an additional leaching step in aqueous 
medium following thermoplastic porogen removal. 
3.2 Mechanical Testing 
To test the mechanical properties of PCL-CaP 
composites we performed compression testing as 
described in Materials and Methods. As seen in Figure 4, 
the increase in CaP content of the composite results in a 
statistically significant increase in compressive modulus 
(CM) and ultimate compressive strength (UCS) of the 
samples (p<0.002, one-tailed t-test assuming unequal 
variances). This is particularly advantageous for making 
scaffolds for application in hard tissue engineering. 
In addition to testing the mechanical properties of 
solid cylinders made of the diverse scaffold materials, we 
tested the compressive strength of pure PCL scaffolds 
with 600µm pore size. Scaffold stress-strain curves show 
DC
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multiple failure points due to failure of the weakest strut, 
followed by collapse of the entire scaffold structure 
(Figure 5). Pure PCL scaffolds had UCS values of 
2.77±0.26MPa and a CM of 44.0±3.2MPa. The UCS 
value is in line with reported values for trabecular bone 
from human mandibles ranging from 0.22~10.44MPa[21]. 
The small standard deviation (<10% coefficient of 
variation) for CM and UCS of the solid cylinders as well 
as 100% PCL scaffolds demonstrates the reproducibility 
of the mechanical properties achieved using this process. 
3.3 Cell-Biomaterial Interactions 
The cytocompatibility of PCL and PCL-CaP 
composite 3-D scaffolds was assessed using the Alamar 
Blue assay for cell metabolic activity/cell proliferation. 
HEPM cells growing on the scaffolds were visualized by 
fluorescent staining of cell nuclei, and SEM. Previously, 
we demonstrated that HEPM cells seeded onto the surface 
of thermoplastic-molded solid disks of calcium phosphate 
cement (CPC) attached and proliferated similarly to 
culture on the “gold standard” TCPS, indicating no 
significant limitations in cellular function due to potential 
residual thermoplastic components[15]. In the case of 3-D 
scaffolds of PCL and 80:20 PCL-CaP, HEPM cells were 
able to attach as evidenced by fluorescent nuclear staining 
with Hoechst 33258 (Figure 6). The images shown in 
Figure 6 indicate attachment onto the struts of both PCL 
(Figure 6A) and 80:20 PCL-CaP composite scaffolds 
(Figure 6B). Based on the Alamar Blue assay, the initial 
seeding efficacy was not significantly different for the 
materials used (data not shown). This similar level of 
HEPM cell attachment to all materials used was probably 
due to the fact that all scaffolds were pre-coated with a 
mixture of Matrigel™, a reconstituted ECM, and collagen 
type I solution. Without this coating, cellular attachment 
to the synthetic surfaces was minimal only (not shown). 
Once attached, HEPM cells proliferated on all types 
of 3D scaffolds, as assessed from the Alamar Blue 
fluorescence data (Figure 7), with some differences 
between materials. The normalized cell proliferation data 
indicated statistically significant (P<0.05 by one-way 
ANOVA with Tukey-Cramer post-tests for multiple 
comparisons) differences between 80:20 PCL-CaP and 
PCL. The enhanced proliferation of the cells on the 80:20 
PCL-CaP composite scaffolds compared to scaffolds 
made of pure PCL, indirectly inferred from the increase in 
a biochemical parameter (increase in Alamar Blue 
fluorescence, commensurate with enhanced cell 
proliferation) was corroborated qualitatively by the 
observed increase in the density of bisbenzimide nuclear 
staining following 4 days of post-seeding in vitro culture 
(Figure 8). We note that at this time point, cells were 
visibly growing both on the struts (Figure 8A and B), as 
well as in the interior pore structures of all scaffolds 
investigated (Figure 8C and D). 
Further confirmation of cellular ingrowth into the 
scaffold center was performed after cutting the scaffolds 
into segments using a scalpel and visualizing the presence 
of cells on all interior surfaces by nuclear staining (Figure 
8E). The histotypic morphology of HEPM cells on PCL 
and 80:20 PCL-CaP composite scaffolds was documented 
by SEM (Figure 9). As seen in Figure 9A the cells flatten 
on the rather smooth PCL surface. By contrast, on the 
80:20 PCL-CaP the cells seem to form multilayer 
assemblies (Figure 9B). This enhanced morphology and 
multiplayer assembly on 80:20 PCL-CaP, as observed by 
SEM, further corroborates the increased density of 
nuclear staining (Figure 8) and significantly higher level 
of cell proliferation (Figure 7) compared to 100% PCL. In 
summary, these cytocompatibility tests clearly indicate 
that all porogen-based scaffolds when coated with 
suitable ECM proteins facilitate attachment and support 
proliferation of HEPM cells in vitro. In addition, our data 
suggest that the presence of CaP in the PCL-CaP 
composite enhances the proliferation and morphology of 
HEPM cells. 
 
 
 
 
 
  
 
Figure 4: Compressive mechanical properties. A: 
Comparison of the compressive modulus of cylinders; B: 
Comparison of the ultimate compressive strength. Bars 
represent mean±standard deviation. Statistical analysis 
indicates that the material properties are significantly 
different for different concentrations of CaP.  
 
 
Figure 5: Typical effective stress-strain curve for 600µm 
100% PCL scaffold.  
 
  
 
Figure 6: Bisbenzimide nuclear staining of adherent 
HEPM cells following 24 hours of orbital shaker seeding 
on PCL (A, 200x) and 80:20 PCL-CaP composite (B, 
100x) scaffolds.  
 
Our findings are in line with previous reports 
showing that PCL scaffolds fabricated using various 
manufacturing processes display good cytocompatibility 
in vitro [18,23] and excellent biocompatibility in vivo[7]. For 
example, Williams et al[7] used selective laser sintering 
(SLS) to fabricate PCL scaffolds which were then seeded 
with human gingival fibroblasts genetically modified to 
express bone morphogenetic protein-7 (BMP- 
B
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7) and implanted into subcutaneous pockets of 
immunocompromised mice. These scaffolds supported the 
development of new bone over a 4 week period, as 
evidenced by micro computed tomography detection of 
mineralized tissue[7]. Darling and Sun[18] reported the in 
vitro biocompatibility of precision extrusion deposition 
fabricated PCL scaffolds using rat cardiomyoblasts, 
however detailed analysis of cellular metabolism, 
proliferation, and morphology were not provided. 
Hutmacher et al.[23] used primary human fibroblasts and 
human osteoprogenitor cells to demonstrate the 
biocompatibility of PCL scaffolds fabricated by fused 
deposition modeling although the capacity of these 
scaffolds to induce bone formation was not addressed. 
 
 
 
 
Figure 7: Normalized increase in Alamar Blue readings 
over the 4 day in vitro culture period following the initial 
24 hour seeding period for 600µm pore size pure PCL, 
90:10 and 80:20 PCL-CaP scaffolds. Y-error bars 
represent the standard deviation from the mean for each 
sample (n = 5). 
 
Diverse scaffolds fabricated from CaP and CaP 
composites also display in vitro[24,25] and in vivo[26] 
biocompatibility. For example, Wang et al.[24] 
demonstrated the capacity of biomimetic nano-structured 
CaP scaffolds fabricated using gel lamination technology 
to support osteogenic differentiation, as evidenced by 
alkaline phosphatase expression. Xu et al.[25] used a 
murine osteoblast cell line to demonstrate 
biocompatibility of CaP-chitosan composites with 
amorphous architecture and pore sizes of 165-270 µm 
fabricated by preparing a water-soluble mannitol mixture 
with the CaP-chitosan, and subsequent removal of 
mannitol to create the pore structure. Amorphous 
poly(lactic-co-glycolic acid) PLGA-CaP scaffolds of 
various weight ratios fabricated by admixing PLGA 
microparticles into Ca-P cement and implanted into 
subcutaneous and cranial defects in rats, facilitated 
fibrovascular and bone tissue development over a 12 
week period, respectively[26]. The primary advantage of 
SFF scaffolds compared to the amorphous CaP scaffolds 
mentioned above is the precisely generated structures that 
in turn allow for reproducible scaffold fabrication with 
control of mechanical properties. 
 
4. Conclusion 
The primary advantage of the porogen-based method 
described in this paper is the ability to use multiple 
biomaterials for injection molding with a single 
ubiquitous porogen. As another advantage, the indirect 
porogen technique can improve the resolution of our SFF 
system by at least 2-fold as compared to directly built 
scaffold fabrication. In this paper, we established a 
thermoplastic porogen-based injection molding 
manufacturing process and demonstrated efficient, 
reproducible fabrication of porous PCL and PCL-CaP 
composite scaffolds with pore sizes as small as 300 µm3. 
With their interconnected porous structure, these scaffolds 
will be suitable for several tissue engineering applications 
such as replacement of trabecular bone, etc. In vitro 
cytocompatibility has been demonstrated for both PCL 
and PCL-CaP scaffolds fabricated using the thermoplastic 
porogen methodology. Future work will focus on 
optimization of mechanical properties and investigating 
the ability to generate mineralized bone tissue constructs 
in vitro using PCL-CaP composite scaffolds seeded with 
mesenchymal stem cells. 
 
 
 
Figure 8: Bisbenzimide staining of HEPM cells cultured 
on PCL (A& B) and 80:20 PCL-CaP composite (C & D) 
scaffolds for 5 days. A: HEPM cells on the surface struts 
of a 600µm pore size PCL scaffold (50x); B: HEPM cells 
growing around and into a pore on the same scaffold 
imaged in A (100x); C: HEPM cells on the surface struts 
of a 600µm pore size 80:20 PCL-CaP composite scaffold 
(50x); D: HEPM cells colonizing a pore in the scaffold 
imaged in C (200x); E: HEPM cells growing on a strut 
from the scaffold center (100x). 
 
 
 
 
 
 
 
 
Figure 9: SEMs of HEPM cells cultured on 600 µm pore 
size PCL and 80:20 PCL-CaP scaffolds for 5 days. A: 
Flattened HEPM cells on PCL scaffold, Scale bar = 50 
µm; B: Multilayered HEPM cells on 80:20 PCL-CaP 
scaffold, scale bar = 20 µm;  
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